Ebos provides more transparency after share price slide
ANALYSIS: The dual-listed healthcare and animal care company is trying to convince investors about its long-term growth drivers.
WATCH: NBR Senior journalist Fiona Rotherham speaks to Simon Shepherd
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Shoeshine, as the doting owner of chocolate labrador Beau, is a bit of sucker for a cute doggy photograph (see below).
Ebos, the dual-listed healthcare and animal care company, therefore didn’t disappoint with a few featuring in its investor day presentation in Australia late last week.
Hubert,
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
